Haemonetics Corporation (HAE) CEO Chris Simon on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha]
Haemonetics Corporation (HAE)
Last haemonetics corporation earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=72118&p=irol-irhome
Company Research
Source: Seeking Alpha
Haemonetics Corporation (HAE) CEO Chris Simon on Q4 2019 Results - Earnings Call Transcript Haemonetics Corporation (NYSE: HAE Company Participants Olga Vlasova – Investor Relations Chris Simon – Chief Executive Officer Bill burke – Chief Financial Officer Conference Call Participants David Lewis – Morgan Stanley Anthony Petrone – Jefferies Dave Turkaly – JMP Securities Larry Keusch – Raymond James Mike Petusky – Barrington Research Operator Good day, ladies and gentlemen, and welcome to the Fourth Quarter and Fiscal 2019 Haemonetics Conference Call and Webcast. [Operator Instructions] As a reminder, this conference call may be recorded. I would now like to introduce your host for today’s conference, Ms. Olga Vlasova, Investor Relations. Good morning. Thank you for joining us for Haemonetics Fourth Quarter and Fiscal 2019 Conference Call and Webcast. I’m joined today by Chris Simon, our CEO; and Bill burke, our CFO. Please note that all revenue growth rates that we’ll refer to on this
Show less
Read more
Impact Snapshot
Event Time:
HAE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HAE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HAE alerts
High impacting Haemonetics Corporation news events
Weekly update
A roundup of the hottest topics
HAE
News
- Global $3.9 Bn Apheresis Market Forecast to 2029: Surge in Use for Leukaemia and Paediatric Patients Boosts Growth Prospects [Yahoo! Finance]Yahoo! Finance
- Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $105.00 price target on the stock.MarketBeat
- Why You Should Add Haemonetics (HAE) to Your Portfolio Now [Yahoo! Finance]Yahoo! Finance
- Apheresis Market Worth $3.9 billion | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024 [Yahoo! Finance]Yahoo! Finance
HAE
Earnings
- 2/8/24 - Beat
HAE
Sec Filings
- 4/17/24 - Form 4
- 4/1/24 - Form 8-K
- 3/13/24 - Form 4
- HAE's page on the SEC website